Bone Marrow TransplantationHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningStem Cell TransplantationBone Marrow CellsBone MarrowTissue DonorsHematologic NeoplasmsTransplantation ChimeraHematopoietic Stem CellsHematopoietic Stem Cell MobilizationStem CellsGraft SurvivalTreatment OutcomeImmunosuppressive AgentsHistocompatibility TestingGranulocyte Colony-Stimulating FactorBusulfanWhole-Body IrradiationLeukemiaHistocompatibilityRecurrenceAntigens, CD34LeukapheresisCombined Modality TherapyMultiple MyelomaMyeloablative AgonistsRemission InductionAnemia, AplasticCytomegalovirus InfectionsCyclophosphamideBone and BonesMelphalanLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsRetrospective StudiesGraft vs Leukemia EffectCord Blood Stem Cell TransplantationBlood Component RemovalLymphocyte DepletionVidarabineAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisDisease-Free SurvivalLymphocyte TransfusionT-LymphocytesGraft vs Tumor EffectImmunosuppressionMyelodysplastic SyndromesSurvival RateGraft RejectionHLA AntigensSalvage TherapyAcute DiseaseLymphoma, Non-HodgkinTransplantation, IsogeneicBone Marrow PurgingChimerismImmunocompromised HostBone Marrow DiseasesMice, Inbred C57BLKidney TransplantationHematologic DiseasesCell DifferentiationOpportunistic InfectionsLeukocyte TransfusionCytomegalovirusFlow CytometrySiblingsAntilymphocyte SerumBlood CellsColony-Forming Units AssayTransplantation ImmunologyCells, CulturedRadiation ChimeraBlood DonorsCyclosporineNeoplasm, ResidualFollow-Up StudiesLeukemia, MyeloidInfectionHepatic Veno-Occlusive DiseaseFatal OutcomeHodgkin DiseaseEtoposideCytarabineMesenchymal Stem Cell TransplantationBlood Cell CountCell SeparationVirus ActivationEmbryonic Stem CellsPrognosisGanciclovir